Last updated: 17-Oct-2026
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Dr Swati Shah
MS, DrNB (Surgical Oncology)
Urology Cancer Surgeon
Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad · 18 years of experience
★★★★★ 4.99 from 84 Google reviews (Gota clinic) · 5.0 from 35 (Apollo, Bhat)
IN SHORT
Before treatment, the tumour is sorted as low risk or high risk. Low risk needs every good feature. High risk needs only one bad one.
Low-risk tumours are usually treated while keeping the kidney. High-risk tumours usually need the kidney, the whole ureter and a bladder cuff removed.
After surgery, the stage on the final report sets the next step. Growth into the muscle wall or the nodes means chemotherapy is offered.
This page is one part of a larger guide. For how ureter and renal pelvis cancer is treated and why the whole ureter is removed, start with our nephroureterectomy guide.
People often hear “stage” and “risk group” as one thing. They are not. The risk group is set before treatment, from scans, urine cells and sometimes a biopsy. The stage is confirmed by the pathologist after the tumour is removed. The risk group chooses the operation. The final stage chooses what comes after it.
| Label | When it is set | What it decides |
|---|---|---|
| Risk group. | Before treatment. | Keep the kidney, or remove the kidney and ureter. |
| T stage. | On the final report after surgery. | Whether chemotherapy follows, and how close follow-up is. |
| Lymph nodes (N). | On scans, then on the final report. | Medicines first if nodes are clearly involved. Chemotherapy after surgery if found then. |
| Grade. | From urine cells, biopsy and the final report. | Low grade grows slowly. High grade behaves more aggressively. |
One high-risk feature is enough to place a tumour in the high-risk group, even when everything else looks reassuring.
| Low risk: all of these | High risk: any one of these |
|---|---|
| One tumour only. | Tumours in more than one place. |
| Smaller than 2 cm. | 2 cm or larger. |
| Low-grade cells in the urine. | High-grade cells in the urine. |
| Low-grade biopsy at ureteroscopy. | High-grade biopsy. |
| No sign of growth into the wall on the CT urogram. | Growth into the wall, a swollen kidney, an unusual cell type, or a past bladder removal for high-grade bladder cancer. |
Stages follow the AJCC system. Figures from large groups of patients are averages, not a forecast for you. So the outlook below is given in words only.
| Stage | What it means | Usual path | Outlook in plain words |
|---|---|---|---|
| Ta or T1, low grade. | In the lining or just under it, with slow-growing cells. | Keep the kidney when every low-risk point is met. | Very good. |
| T1, high grade. | Just under the lining, with aggressive cells. | Remove the kidney and ureter. Keep the kidney only if removal would mean dialysis. | Good for most people. |
| T2. | Into the muscle wall. | Removal, then chemotherapy. | A real chance of return. Chemotherapy after surgery lowers it. |
| T3. | Through the wall into fat or kidney tissue. | Removal, then chemotherapy. | A higher chance of return. Close follow-up. |
| T4, or lymph nodes involved. | Into nearby organs, or in the nodes. | Medicines first. Surgery only after a team review. | Usually controlled rather than removed. |
The wall of the ureter is thinner than the wall of the kidney’s drainage space. A tumour needs less growth to get through it. So the same T stage carries a worse outlook in the ureter. Some other features also raise the risk, whatever the stage:
Keeping the kidney is the first choice when every low-risk point is met. It is also offered when removing the kidney would mean dialysis.
That includes a single working kidney, tumours on both sides, or kidney function already badly reduced. A tumour inside the kidney’s drainage space or the upper ureter is treated with a laser through a thin telescope. A tumour low in the ureter is removed with that segment, and the ureter is joined back to the bladder. A second look with the telescope within 8 weeks is part of the treatment. Checks under anaesthesia then continue for life. The tumour can come back, and the kidney may still need removing later. Keeping the kidney is a joint decision about accepting that risk. If a second look cannot be assured, it should not be offered.
For a high-risk tumour, the kidney, the whole ureter and a small cuff of bladder are removed together, in one piece.
This is explained on the nephroureterectomy page. When the tumour reaches the muscle wall, lymph nodes on that side are removed to a set pattern. This gives an accurate stage, and probably helps treat the cancer. Tumours confined to the kidney and ureter are removed by keyhole or robotic surgery. Bulky tumours are removed by open surgery.
If the final report shows T2, T3, T4 or involved nodes, platinum chemotherapy is offered. It should start within 90 days of surgery.
Kidney function falls after a kidney is removed. Some people who could have cisplatin before surgery cannot have it after. Carboplatin is used then, though the evidence for it is weaker. This is why the cancer medicine visit is booked before you leave hospital. Immunotherapy may also be discussed. It can keep the cancer away for longer, but a gain in overall survival is not yet proven, and its cost is high. After any removal, a single dose of chemotherapy goes into the bladder within 10 days.
| Situation | Bladder camera checks and urine cells | CT urogram |
|---|---|---|
| High risk, after removal. | Every 3 months for 2 years, then every 6 months up to 5 years. | Every 6 months for 2 years, then yearly. |
| Low risk, after removal. | At 3 and 9 months, then yearly. | Yearly. |
| After keeping the kidney. | A second telescope look within 8 weeks, then checks at 3 and 6 months, then every 6 months for 2 years. | With each check, then yearly. |
| Everyone. | Yearly for life. These checks never stop. | Yearly, or an ultrasound with a creatinine test. |
No. The stage says how deep or how far the cancer has grown. The grade says how aggressive the cells look. Both matter.
Only when removing the kidney would mean dialysis, such as with a single kidney. It is then a carefully shared decision, with lifelong checks.
Not always. The tumour can come back, and the kidney may need removing later. Regular telescope checks look for this.
Clearly involved nodes are treated with medicines first. Surgery is considered only after the cancer team reviews the response.
After surgery is the standard for tumours in the muscle wall or deeper. Before surgery is considered only case by case, when kidney function is borderline.
The operation and kidney-sparing choices are explained on the nephroureterectomy page. The early signs are covered on the ureter cancer signs page. For questions before you travel, call +91-63590-11009.
Shah’s Gastro, Cancer & Robotic Surgery Centre
Dr Swati Shah — MS, DrNB (Surgical Oncology) · Urology Cancer Surgeon
Consultation: Gota OPD, Gota, Ahmedabad. Surgery: Apollo Hospital, Bhat, Gandhinagar.
Gota OPD — Gota, Ahmedabad, Gujarat
Apollo Hospital, Bhat, Gandhinagar — Apollo Hospital International Limited, Plot No. 1 A, GIDC Bhat Industrial Estate, Bhat, Gandhinagar, Gujarat
Call: +91-63590-11009 · WhatsApp: +91-63590-11009
Have a CT urogram or a biopsy report and want to know your risk group? Bring the reports to the consultation. Your risk group and stage are explained at the consultation, after the reports and images are read. Call +91-63590-11009 Bring your reports to the visit
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
